Literature DB >> 26865073

Molecular Epidemiological Characterization and Health Burden of Thalassemias in the Chaoshan Region, People's Republic of China.

Xiangbin Zheng1, Min Lin1, Hui Yang1, Mei-Chen Pan2, Ying-Mu Cai2, Jiao-Ren Wu1, Fen Lin1, Xiao-Fen Zhan1, Zhao-Yun Luo1, Hui-Tian Yang1, Li-Ye Yang1.   

Abstract

Thalassemia is one of the most prevalent inherited disease in southern China. However, there have been only a few epidemiological studies of thalassemia in the Chaoshan region of Guangdong Province, People's Republic of China (PRC). A total of 6231 unrelated subjects in two main geographical cities of the Chaoshan region was analyzed for thalassemia. Seven hundred and thirty-six cases of suspected thalassemia carriers with microcytosis [mean corpuscular volume (MCV) <82.0 fL] were found by complete blood cell (CBC) count, and were tested by reverse dot-blot gene chip to reveal a total of 331 mutant chromosomes, including 278 α-thalassemia (α-thal) alleles and 53 β-thalassemia (β-thal) alleles. The most common α-thal mutations were the Southeast Asian (- -(SEA)), followed by the -α(3.7) (rightward) and -α(4.2) (leftward) deletions. The two most common β-thal mutations were HBB: c.316-197C>T and HBB: c.126_129delCTTT, accounting for 69.81% of the β-thal defects in the studied individuals. In addition, a rare mutation, Cap +1 (A>C) (HBB: c.-50A>C) was described for the first time in the Chaoshan region. Our results gave a heterozygote frequency of 5.31% for common α- and β-thal in the Chaoshan region, and also indicated a higher prevalence of thalassemia with a heterozygote frequency of 6.29% in Chaozhou, followed by Shantou (3.37%). This study provided a detailed prevalence and molecular characterization of thalassemia in the Chaoshan region, and will be valuable for developing a strategy for prevention of thalassemia and reducing excessive health care costs in this area.

Entities:  

Keywords:  Chaoshan region; health burden; molecular epidemiological survey; mutation; thalassemia

Mesh:

Substances:

Year:  2016        PMID: 26865073     DOI: 10.3109/03630269.2015.1137933

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.

Authors:  Lin Zheng; Hailong Huang; Xiaoqing Wu; Qingmei Shen; Meihuan Chen; Meiying Wang; Linjuan Su; Liangpu Xu
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-27       Impact factor: 0.900

2.  [Diagnosis and therapeutic outcomes of 12 cases thalassemia with concomitant acquired bone marrow failure].

Authors:  S B Fan; J Shi; N Nie; Y Q Shao; Z D Huang; J Zhang; J B Huang; X X Li; M L Ge; Y Z Zheng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-12-14

3.  Molecular analysis of alpha- and beta-thalassemia in Meizhou region and comparison of gene mutation spectrum with different regions of southern China.

Authors:  Heming Wu; Qingyan Huang; Zhikang Yu; Zhixiong Zhong
Journal:  J Clin Lab Anal       Date:  2021-11-09       Impact factor: 2.352

4.  Clinical validation of a single-tube PCR and reverse dot blot assay for detection of common α-thalassaemia and β-thalassaemia in Chinese.

Authors:  Hong-Feng Liang; Lie-Jun Li; Hui Yang; Xiang-Bin Zheng; Min Lu; Yi-Yuan Ge; Fen Lin; Long-Xu Xie; Li-Ye Yang
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.